FDA approves first gene therapy for deafness

The FDA approved the first gene therapy for deafness, restoring hearing in people born with a rare OTOF gene defect. Treatment uses viruses to deliver a healthy gene, with 80% of patients gaining significant hearing. It's hailed as a landmark for hearing loss treatment.